Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis

BACKGROUND: International guidelines recommend using basal insulin in patients with type-2 diabetes mellitus if glycaemic target cannot be attained on non-insulin anti-diabetic drugs. Available choices of basal insulin include intermediate-acting neutral protamine Hagedorn (NPH) insulin and long-act...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, E., Salem, A., Chan, J. C. N., So, W. Y., Kong, A., Lamotte, M., Luk, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604305/
https://www.ncbi.nlm.nih.gov/pubmed/31303866
http://dx.doi.org/10.1186/s12962-019-0180-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604305/
https://www.ncbi.nlm.nih.gov/pubmed/31303866
http://dx.doi.org/10.1186/s12962-019-0180-9

Ejemplares similares